Pharmaniaga Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	54.3	68.68	114.74	52.85	47.11
Short-Term Investments	217.3	223.27	67.36	2.87	4.11	10.25
Cash & Short-Term Investments	217.3	277.57	136.04	117.61	56.96	57.36
Cash Growth	57.25%	104.04%	15.67%	106.48%	-0.70%	40.85%
Accounts Receivable	672.08	324.55	337.63	285.22	261.75	227.85
Other Receivables	11.07	97.52	86.98	84.4	76.77	44.1
Receivables	683.15	422.06	424.6	369.62	338.52	271.95
Inventory	665.61	729.82	612.79	580.64	767.26	1,264
Prepaid Expenses	-	16.49	11.06	26.9	32.06	27.52
Restricted Cash	-	18.3	19.8	12.7	-	-
Total Current Assets	1,566	1,464	1,204	1,107	1,195	1,621
Property, Plant & Equipment	598.66	602.78	609.36	605.75	443.03	395.59
Goodwill	-	77.03	77.31	77.47	77.34	129.48
Other Intangible Assets	151.23	22.65	28.25	23.8	72.39	75.31
Long-Term Deferred Tax Assets	41.45	28.15	27.34	52.08	48.89	33.07
Long-Term Deferred Charges	-	51.97	45.76	48.3	10.83	3.23
Total Assets	2,357	2,247	1,992	1,915	1,847	2,258
Accounts Payable	988.61	776.48	650.1	627.78	648.02	677.63
Accrued Expenses	0.38	40.47	96.19	91.6	46.78	31.53
Short-Term Debt	687.53	527.49	771.26	711.18	681.3	543.98
Current Portion of Long-Term Debt	-	162.55	283.41	335.87	384.45	25.7
Current Portion of Leases	2.62	3.99	4.48	4.62	5.67	1.57
Current Income Taxes Payable	7.84	6.97	10.46	9.8	4.27	14.44
Current Unearned Revenue	19.96	11.69	29.76	9.16	31.28	22.46
Other Current Liabilities	-	81.45	107.43	212.44	265.93	150.46
Total Current Liabilities	1,707	1,611	1,953	2,002	2,068	1,468
Long-Term Debt	109.67	125.4	129.57	138.62	91.67	284.99
Long-Term Leases	-	0.37	3.18	1.09	5	0.62
Long-Term Unearned Revenue	15.15	15.22	14.51	3.1	3.36	3.62
Pension & Post-Retirement Benefits	10.32	10.56	10.79	10.84	9.05	9.08
Long-Term Deferred Tax Liabilities	25.83	25.05	27.13	32.85	18.82	21.35
Total Liabilities	1,868	1,788	2,138	2,189	2,196	1,787
Common Stock	243.43	243.43	200.05	200.05	154.19	154.05
Retained Earnings	-	97.06	-471.41	-603.42	-525.23	293.73
Comprehensive Income & Other	221.19	93.98	100.09	104.31	1.34	2.69
Total Common Equity	464.62	434.47	-171.28	-299.07	-369.69	450.46
Minority Interest	24.89	24.69	25.33	24.98	21.39	19.98
Shareholders' Equity	489.5	459.16	-145.94	-274.09	-348.31	470.44
Total Liabilities & Equity	2,357	2,247	1,992	1,915	1,847	2,258
Total Debt	799.81	819.79	1,192	1,191	1,168	856.86
Net Cash (Debt)	-582.5	-542.22	-1,056	-1,074	-1,111	-799.5
Net Cash Per Share	-0.12	-0.15	-0.73	-0.79	-0.85	-0.61
Filing Date Shares Outstanding	6,556	6,557	1,441	1,441	1,310	1,310
Total Common Shares Outstanding	6,556	6,557	1,441	1,441	1,310	1,310
Working Capital	-140.86	-146.85	-748.78	-894.98	-872.9	153.43
Book Value Per Share	0.07	0.07	-0.12	-0.21	-0.28	0.34
Tangible Book Value	313.39	334.79	-276.83	-400.33	-519.43	245.68
Tangible Book Value Per Share	0.05	0.05	-0.19	-0.28	-0.40	0.19
Land	-	394.94	393.11	394.01	25.66	25.55
Buildings	-	-	-	-	254.02	255.22
Machinery	-	503.78	503.2	497.02	444.29	430.76
Construction In Progress	-	142.41	125.81	109.28	75.42	30.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.